GB Patent

GB2056982A — 2 - phenylimidazo(2,1 - b)benzothiazole derivatives

Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1981-03-25 · 45y expired

What this patent protects

Patent listed against quizartinib-dihydrochloride.

Drugs covered by this patent

quizartinib-dihydrochloride (QUIZARTINIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: GB2056982A
Jurisdiction: GB
Classification: —
Expires: 1981-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Yamanouchi Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.